provider portal
Wesper Journal
Living with sleep apnea often means battling invisible exhaustion due to repeated interruptions in breathing during sleep, which leads to extreme fatigue and affects daily functioning. This condition's impact on emotional health, relationships, and overall quality of life is significant,...
Continue reading
Did you know that sleep disorders, like sleep apnea, can significantly impact your health if not diagnosed and treated properly? Understanding how to diagnose these conditions is crucial for effective treatment. This article explores two main methods for diagnosing sleep...
Continue reading
Zepbound (tirzepatide) has received FDA approval for the treatment of obstructive sleep apnea, now included in Medicare coverage to help manage the condition alongside obesity. This approval marks a shift towards a holistic approach, combining medication with real-time monitoring for...
Continue reading
GLP-1 therapies, such as Zepbound (tirzepatide), address obstructive sleep apnea by aiding weight management, thereby reducing airway pressure and improving respiratory health. Wesper's wearable technology enhances treatment by providing continuous monitoring, allowing for timely adjustments to therapy plans. FDA’s Landmark...
Continue reading
GLP-1 Receptor Agonists and Obstructive Sleep Apnea (OSA): A New Era in Sleep Health ManagementThe approval of GLP-1 receptor agonists, such as Zepbound (tirzepatide), represents a groundbreaking development in the treatment of Obstructive Sleep Apnea (OSA). These medications not only...
Continue reading